Imunon (IMNN) Q4 2024 Earnings Call February 27, 2025 11:00 AM ET Company Participants Peter Vozzo - Managing DirectorStacy Lindborg - President, CEO & DirectorDouglas Faller - Chief Medical OfficerDavid Gaiero - Chief Financial OfficerJoey Brusca - Equity Research AssociateKhursheed Anwer - Executive VP & Chief Scientific OfficerJason Kolbert - Managing Director Conference Call Participants David Bautz - Senior AnalystJames Molloy - Managing Director, Senior Biotechnology & Specialty Pharmaceuticals Equity ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Mary Jenkins - Associate Director, Investor Relations and Corporate Communications Doug Ingram - President and CEO Ian Estepan - Executive Vice President and CFO Dallan Murray - Executive Vice President and CCO Dr. Louise Rodino-Klapac - Executive Vice President, Chief Scientific Officer and Head, Research & Development Conference Call Participants Tazeen Ahmad - Bank of America Securi ...

Lexeo Therapeutics (LXEO) Conference February 06, 2025 01:30 PM ET Company Participants Debjit Chattopadhyay - Managing DirectorKyle Rasbach - CFOSandi See Tai - Chief Development Officer Debjit Chattopadhyay Alright. Good afternoon, and thank you for joining Guggenheim Therapeutics team, on our second Smith Gap Conference. I am Devjit, one of the therapeutic analysts. And joining me on stage from Lexio Therapeutics are Sandy C. Sai, chief development officer, and Kyle Raschbach, CFO. Thank you for making t ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Conference Call February 29, 2024 4:30 PM ET Company Participants Troy Wichterman - CFO Rod de Greef - Chairman and CEO Conference Call Participants Paul Knight - KeyBanc Jacob Johnson - Stephen Steven Mah - TD Cowen Thomas Flaten - Lake Street Jack Siedow - Craig-Hallum Michael Okunewitch - Maxim Group Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Q4, 2023 Shareholder and Analyst Conferen ...

Maravai LifeSciences (MRVI) FY 2023 Conference November 16, 2023 09:00 AM ET Speaker0 Good afternoon. Thanks for being here at the last session of our London conference. We're very excited to have Maribai Life Sciences with us today here to tell us more about the story before we jump into some Q and A, CEO, Trey Martin as well as CFO, Kevin Hurti. Turn it over to Trey. Speaker1 All right. Thank you. Thanks for being here in person. I know it sounds like we're at the tail end of this conference. And also tha ...